Michael Findlay

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

J. Philip Kuebler, H. Samuel Wieand, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Peter Gibbs, Navesh Sharma et al. · The Lancet Oncology · 2017 · 378 citations · Full text

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

Guy A. Van Hazel, Volker Heinemann, Navesh Sharma et al. · Journal of Clinical Oncology · 2016 · 339 citations

Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study

Eric Van Cutsem, Michael Findlay, B Osterwalder et al. · Journal of Clinical Oncology · 2000 · 322 citations

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.

Michael Findlay, Helen Young, David Cunningham et al. · Journal of Clinical Oncology · 1996 · 312 citations